Adriana Tomic, PhD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Adriana Tomic, PhD, specializes in systems immunology, focusing on human immunological memory and recall responses. As an Assistant Professor at Boston University, she leads a research team that integrates multi-omics data and machine learning to study immune system dynamics and improve vaccine effectiveness.
Her expertise includes the development of recombinant cytomegalovirus as live attenuated vaccine candidates and the creation of the SIMON machine learning platform for biomedical data analysis. Adriana's work on the ChAdOx1 nCoV-19 vaccine and her widely published research in journals like The Lancet and Nature Immunology highlight her significant contributions to vaccine development and global health.

Publications

  • Published 4/14/2025

    Brady C, Tipton T, Carnell O, Longet S, Gooch K, Hall Y, Salguero J, Tomic A, Carroll M. A systems biology approach to define SARS-CoV-2 correlates of protection. NPJ Vaccines. 2025 Apr 14; 10(1):69. PMID: 40229322.

    Read at: PubMed

  • Published 1/23/2025

    Hao S, Tomic I, Lindsey BB, Jagne YJ, Hoschler K, Meijer A, Quiroz JMC, Meade P, Sano K, Peno C, Costa-Martins AG, Bogaert D, Kampmann B, Nakaya H, Krammer F, de Silva TI, Tomic A. Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response Prediction. bioRxiv. 2025 Jan 23. PMID: 39896552.

    Read at: PubMed

  • Published 9/16/2024

    Ali M, Longet S, Neale I, Rongkard P, Chowdhury FUH, Hill J, Brown A, Laidlaw S, Tipton T, Hoque A, Hassan N, Hackstein CP, Adele S, Akther HD, Abraham P, Paul S, Rahman MM, Alam MM, Parvin S, Mollah FH, Hoque MM, Moore SC, Biswas SK, Turtle L, de Silva TI, Ogbe A, Frater J, Barnes E, Tomic A, Carroll MW, Klenerman P, Kronsteiner B, Chowdhury FR, Dunachie SJ. Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery. Clin Exp Immunol. 2024 Sep 16; 218(1):78-92. PMID: 38642547.

    Read at: PubMed

  • Published 9/1/2023

    Neale I, Ali M, Kronsteiner B, Longet S, Abraham P, Deeks AS, Brown A, Moore SC, Stafford L, Dobson SL, Plowright M, Newman TAH, Wu MY, Carr EJ, Beale R, Otter AD, Hopkins S, Hall V, Tomic A, Payne RP, Barnes E, Richter A, Duncan CJA, Turtle L, de Silva TI, Carroll M, Lambe T, Klenerman P, Dunachie S. CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study. mBio. 2023 Oct 31; 14(5):e0121223. PMID: 37655880.

    Read at: PubMed

  • Published 8/21/2023

    Hornsby H, Nicols AR, Longet S, Liu C, Tomic A, Angyal A, Kronsteiner B, Tyerman JK, Tipton T, Zhang P, Gallis M, Supasa P, Selvaraj M, Abraham P, Neale I, Ali M, Barratt NA, Nell JM, Gustafsson L, Strickland S, Grouneva I, Rostron T, Moore SC, Hering LM, Dobson SL, Bibi S, Mongkolsapaya J, Lambe T, Wootton D, Hall V, Hopkins S, Dong T, Barnes E, Screaton G, Richter A, Turtle L, Rowland-Jones SL, Carroll M, Duncan CJA, Klenerman P, Dunachie SJ, Payne RP, de Silva TI. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history. Nat Commun. 2023 Aug 21; 14(1):5065. PMID: 37604803.

    Read at: PubMed